oasis 1 oral semaglutide 50 mg nejm 2023 obesity Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had ≥1 weight-related complication, individuals assigned to a combination The Science | ReMedical

A deeper understanding of the interplay between metabolic reprogramming and efferocytosis will provide a theoretical foundation and novel targets for treating diseases associated with impaired clearance of apoptotic cells

Since the FDA restricted most compounded semaglutide versions in 2025, compounded semaglutide is no longer available (except in specific circumstances)

Lancet Diabetes Endocrinol 4(11):913921

BPC-157, or Body Protection Compound 157, is a synthetic peptide derived from a portion of the body's own protein known as Body Protection Compound

This is particularly important during seasonal changes or times of increased physical stress, and the Immunity supplements collection can help you explore supportive formulas in that category

Your GP or pharmacist will review this with you